Using the Cloud to Meet Pharmacovigilance Requirements and Maintain Global Compliance, New Webinar Hosted by Xtalks
/EINPresswire.com/ -- TORONTO, ON--(Marketwired - July 27, 2016) - Keeping up with the increasing and evolving safety and pharmacovigilance obligations around the globe can be a major challenge. In this webinar, industry expert Nicole Baker, Director of Drug Safety at Bioclinica, will examine upcoming changes in global drug safety regulatory requirements.
Topics will include:
- The global outlook on drug safety and the current regulatory environment
- The new clinical trial Regulation EU No 536/2014
- Eudravigilance ISO ICSR updates
Baker will also demonstrate Bioclinica's drug safety regulatory intelligence tool, RITrace, and how it can improve efficiencies and help you remain compliant.
The live broadcast takes place on Wednesday, August 10, 2016 at 11am EDT (4pm BST/UK). For more information or to register for this complimentary event, visit: Using the Cloud to Meet Pharmacovigilance Requirements and Maintain Global Compliance
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2016/7/26/11G108139/Images/Bioclinical_TransparentLogo_200-336767260496a206aa017efc5a3851ae.jpg
Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
